Free Trial

Syndax Pharmaceuticals (SNDX) Insider Trading & Ownership

Syndax Pharmaceuticals logo
$13.08 +0.23 (+1.79%)
(As of 12/20/2024 05:40 PM ET)

Syndax Pharmaceuticals (NASDAQ:SNDX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.10%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$25,037.50
Number Of
Insiders Selling
(Last 12 Months)
0
Get SNDX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Syndax Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SNDX Insider Buying and Selling by Quarter

Syndax Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2024Keith A GoldanCFOBuy1,250$20.03$25,037.50  
(Data available from 1/1/2013 forward)

SNDX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Syndax Pharmaceuticals includes Alexander Nolte, Briggs Morrison, Dennis Podlesak, Keith A Goldan, Keith Katkin, Michael A Metzger, Peter Ordentlich, Pierre Legault, and William Meury. Learn more on insiders at SNDX.

4.10% of Syndax Pharmaceuticals stock is owned by insiders. Learn more on SNDX's insider holdings.

The following insider purchased SNDX shares in the last 24 months: Keith A Goldan ($25,037.50).

Insiders have purchased a total of 1,250 SNDX shares in the last 24 months for a total of $25,037.50 bought.

The following insiders have sold SNDX shares in the last 24 months: Briggs Morrison ($7,936,128.89), Keith A Goldan ($12,872.87), Michael A Metzger ($164,706.76), Peter Ordentlich ($646,000.00), Pierre Legault ($641,760.00), and William Meury ($1,698,180.00).

Insiders have sold a total of 508,519 Syndax Pharmaceuticals shares in the last 24 months for a total of $11,099,648.52 sold.

Syndax Pharmaceuticals Key Executives

  • Mr. Michael A. Metzger M.B.A.Mr. Michael A. Metzger M.B.A. (Age 53)
    CEO & Director
    Compensation: $1.1M
  • Dr. Peter Ordentlich B.Sc. (Age 55)
    Ph.D., Co-Founder & Chief Scientific Officer
  • Dr. Richard A. Heyman Ph.D. (Age 67)
    Co-Founder
  • Dr. Ronald M. Evans Ph.D. (Age 75)
    Co-Founder, Advisor and Chair of Scientific Advisory Board
  • Dr. Michael Downes Ph.D.
    Co-Founder
  • Sharon Klahre
    Vice President of Investor Relations & Communications
  • Mr. Kevin McManus (Age 55)
    Chief People Officer
  • Dr. Joseph Paul Eder M.D.
    Member of Scientific Advisory Board & Chief Medical Officer
  • Dr. Anjali Ganguli Ph.D. (Age 47)
    Chief Business Officer
    Compensation: $450.58k
  • Mr. Steven Closter
    Chief Commercial Officer


This page (NASDAQ:SNDX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners